MICALLEF JACOB VINCENT (Chief Scientific Officer) purchased 57.1% of their position (20K shares) of VOLITIONRX LTD on the open market
Open‑market purchase worth $25.1K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/31/2023ACC: 0001477932-23-006539
Officer· Chief Scientific Officer
+20K
Net shares
Net buyer
$25.1K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
20K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+11.25K
Price / share
$1.24
Trade value
$13.95K
% of position
32.1%
—
35K→46.25K
Common Stock
Indirect
Shares
+8.75K
Price / share
$1.27
Trade value
$11.11K
% of position
18.9%
—
46.25K→55K
Total
Net shares
+20K
Net value
$25.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | — | P · Purchase | +11.25K | $1.24 | $13.95K | 32.1% | 35K | 46.25K |
| Common Stock Indirect | — | P · Purchase | +8.75K | $1.27 | $11.11K | 18.9% | 46.25K | 55K |
| Total | +20K | $25.06K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned235.14K
Common Stock
IndirectShares owned38.11K
Total
235.14K direct·38.11K indirect273.25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 235.14K | Direct |
| Common Stock | 38.11K | Indirect |
| Total | 273.25K | 235.14K direct·38.11K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported